These tools will no longer be maintained as of December 31, 2024. Archived website can be found here. PubMed4Hh GitHub repository can be found here. Contact NLM Customer Service if you have questions.
22. Genetic factors associated with age-related macular degeneration: identification of a novel PRPH2 single nucleotide polymorphism associated with increased risk of the disease. Ulańczyk Z; Grabowicz A; Mozolewska-Piotrowska K; Safranow K; Kawa MP; Pałucha A; Krawczyk M; Sikora P; Matczyńska E; Machaliński B; Machalińska A Acta Ophthalmol; 2021 Nov; 99(7):739-749. PubMed ID: 33354892 [TBL] [Abstract][Full Text] [Related]
23. PRPH2-Associated Macular Dystrophy in 4 Family Members with a Novel Mutation. Choi H; Cloutier A; Lally D Ophthalmic Genet; 2022 Apr; 43(2):235-239. PubMed ID: 34906036 [TBL] [Abstract][Full Text] [Related]
30. Cone-rod dystrophy, intrafamilial variability, and incomplete penetrance associated with the R172W mutation in the peripherin/RDS gene. Michaelides M; Holder GE; Bradshaw K; Hunt DM; Moore AT Ophthalmology; 2005 Sep; 112(9):1592-8. PubMed ID: 16019073 [TBL] [Abstract][Full Text] [Related]
31. Retinal dystrophies and variants in PRPH2. Palma MMD; Martin D; Salles MV; Motta FLT; Abujamra S; Sallum JMF Arq Bras Oftalmol; 2019; 82(2):158-160. PubMed ID: 30726412 [TBL] [Abstract][Full Text] [Related]
32. ABCA4 and ROM1: implications for modification of the PRPH2-associated macular dystrophy phenotype. Poloschek CM; Bach M; Lagrèze WA; Glaus E; Lemke JR; Berger W; Neidhardt J Invest Ophthalmol Vis Sci; 2010 Aug; 51(8):4253-65. PubMed ID: 20335603 [TBL] [Abstract][Full Text] [Related]
33. RPE65-related retinal dystrophy: Mutational and phenotypic spectrum in 45 affected patients. Lopez-Rodriguez R; Lantero E; Blanco-Kelly F; Avila-Fernandez A; Martin Merida I; Del Pozo-Valero M; Perea-Romero I; Zurita O; Jiménez-Rolando B; Swafiri ST; Riveiro-Alvarez R; Trujillo-Tiebas MJ; Carreño Salas E; García-Sandoval B; Corton M; Ayuso C Exp Eye Res; 2021 Nov; 212():108761. PubMed ID: 34492281 [TBL] [Abstract][Full Text] [Related]
34. Daftarian N; Mirrahimi M; Sabbaghi H; Moghadasi A; Zal N; Dehghan Banadaki H; Ahmadieh H; Suri F Ophthalmic Genet; 2019 Oct; 40(5):436-442. PubMed ID: 31618092 [No Abstract] [Full Text] [Related]
35. The Interplay between Peripherin 2 Complex Formation and Degenerative Retinal Diseases. Tebbe L; Kakakhel M; Makia MS; Al-Ubaidi MR; Naash MI Cells; 2020 Mar; 9(3):. PubMed ID: 32213850 [TBL] [Abstract][Full Text] [Related]
36. Gene therapy for PRPH2-associated ocular disease: challenges and prospects. Conley SM; Naash MI Cold Spring Harb Perspect Med; 2014 Aug; 4(11):a017376. PubMed ID: 25167981 [TBL] [Abstract][Full Text] [Related]
37. Novel variants identified with next-generation sequencing in Polish patients with cone-rod dystrophy. Wawrocka A; Skorczyk-Werner A; Wicher K; Niedziela Z; Ploski R; Rydzanicz M; Sykulski M; Kociecki J; Weisschuh N; Kohl S; Biskup S; Wissinger B; Krawczynski MR Mol Vis; 2018; 24():326-339. PubMed ID: 29769798 [TBL] [Abstract][Full Text] [Related]
38. ROM1 contributes to phenotypic heterogeneity in PRPH2-associated retinal disease. Strayve D; Makia MS; Kakakhel M; Sakthivel H; Conley SM; Al-Ubaidi MR; Naash MI Hum Mol Genet; 2020 Sep; 29(16):2708-2722. PubMed ID: 32716032 [TBL] [Abstract][Full Text] [Related]
39. Prph2 mutations as a cause of electronegative ERG. Ba-Abbad R; Robson AG; Yap YC; Moore AT; Webster AR; Holder GE Retina; 2014 Jun; 34(6):1235-43. PubMed ID: 24608669 [TBL] [Abstract][Full Text] [Related]
40. PRPH2/RDS and ROM-1: Historical context, current views and future considerations. Stuck MW; Conley SM; Naash MI Prog Retin Eye Res; 2016 May; 52():47-63. PubMed ID: 26773759 [TBL] [Abstract][Full Text] [Related] [Previous] [Next] [New Search]